Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universe Pharmaceuticals (UPC) Current Deferred Tax Assets (2021)

Universe Pharmaceuticals (UPC) has disclosed Current Deferred Tax Assets for 1 consecutive years, with $7.5 million as the latest value for Q3 2021.

  • Quarterly Current Deferred Tax Assets changed N/A to $7.5 million in Q3 2021 from the year-ago period, while the trailing twelve-month figure was $7.5 million through Sep 2021, changed N/A year-over-year, with the annual reading at $7.5 million for FY2021, N/A changed from the prior year.
  • Current Deferred Tax Assets hit $7.5 million in Q3 2021 for Universe Pharmaceuticals.
  • In the past five years, Current Deferred Tax Assets ranged from a high of $7.5 million in Q3 2021 to a low of $7.5 million in Q3 2021.